MYC and cervical carcinoma: Amplification, rearrangement or hypomethylation of the MYC oncogene are genetic alterations frequently occurring in many cancers, as carcinoma of the cervix, colon, breast, lung and stomach [7–11], and causing MYC to be activated and over-expressed.